BIOMAT Database Logo BIOMAT Database Logo

Divergent modes of enzyme inhibition in a homologous structure-activity series. 2009

Rafaela S Ferreira, and Clifford Bryant, and Kenny K H Ang, and James H McKerrow, and Brian K Shoichet, and Adam R Renslo
Small Molecule Discovery Center, Sandler Center for Basic Research in Parasitic Diseases, and Department of Pharmaceutical Chemistry, University of California, San Francisco, 1700 4th Street, San Francisco, CA 94158, USA.

A docking screen identified reversible, noncovalent inhibitors (e.g., 1) of the parasite cysteine protease cruzain. Chemical optimization of 1 led to a series of oxadiazoles possessing interpretable SAR and potencies as much as 500-fold greater than 1. Detailed investigation of the SAR series subsequently revealed that many members of the oxadiazole class (and surprisingly also 1) act via divergent modes of inhibition (competitive or via colloidal aggregation) depending on the assay conditions employed.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010069 Oxadiazoles Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms. Oxadiazole
D003102 Colloids Two-phase systems in which one is uniformly dispersed in another as particles small enough so they cannot be filtered or will not settle out. The dispersing or continuous phase or medium envelops the particles of the discontinuous phase. All three states of matter can form colloids among each other. Hydrocolloids,Colloid,Hydrocolloid
D003546 Cysteine Endopeptidases ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
D006016 Glycolates Derivatives of ACETIC ACID which contain an hydroxy group attached to the methyl carbon. 2-Hydroxyacetates,Glycolate Ethers,Hydroxyacetate Ethers,Hydroxyacetates,Hydroxyacetic Acids,2 Hydroxyacetates,Acids, Hydroxyacetic,Ethers, Glycolate,Ethers, Hydroxyacetate
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014344 Trypanocidal Agents Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. Trypanocidal Drugs,Trypanocides,Trypanosomicidal Agents,Trypanosomicides,Agents, Trypanocidal,Agents, Trypanosomicidal,Drugs, Trypanocidal
D014349 Trypanosoma cruzi The agent of South American trypanosomiasis or CHAGAS DISEASE. Its vertebrate hosts are man and various domestic and wild animals. Insects of several species are vectors. Trypanosoma cruzus,cruzi, Trypanosoma
D015800 Protozoan Proteins Proteins found in any species of protozoan. Proteins, Protozoan
D015853 Cysteine Proteinase Inhibitors Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES. Acid Cysteine Proteinase Inhibitor,Cysteine Protease Inhibitor,Cysteine Protease Inhibitors,Cysteine Proteinase Antagonist,Cysteine Proteinase Antagonists,Cysteine Proteinase Inhibitor,Cysteine Proteinase Inhibitors, Endogenous,Cysteine Proteinase Inhibitors, Exogenous,alpha-Cysteine Protease Inhibitor,Acid Cysteine Proteinase Inhibitors,alpha-Cysteine Protease Inhibitors,Antagonist, Cysteine Proteinase,Antagonists, Cysteine Proteinase,Inhibitor, Cysteine Protease,Inhibitor, Cysteine Proteinase,Inhibitor, alpha-Cysteine Protease,Inhibitors, Cysteine Protease,Inhibitors, Cysteine Proteinase,Inhibitors, alpha-Cysteine Protease,Protease Inhibitor, Cysteine,Protease Inhibitor, alpha-Cysteine,Protease Inhibitors, Cysteine,Protease Inhibitors, alpha-Cysteine,Proteinase Antagonist, Cysteine,Proteinase Antagonists, Cysteine,Proteinase Inhibitor, Cysteine,Proteinase Inhibitors, Cysteine,alpha Cysteine Protease Inhibitor,alpha Cysteine Protease Inhibitors

Related Publications

Rafaela S Ferreira, and Clifford Bryant, and Kenny K H Ang, and James H McKerrow, and Brian K Shoichet, and Adam R Renslo
Metabolic structure-activity relationship for a homologous series of phenacetin analogs.
April 1979, The Journal of pharmacology and experimental therapeutics,
Rafaela S Ferreira, and Clifford Bryant, and Kenny K H Ang, and James H McKerrow, and Brian K Shoichet, and Adam R Renslo
Structure-activity correlations in a homologous series of 2-substituted isonicotinic acid hydrazides.
January 1976, Experientia. Supplementum,
Rafaela S Ferreira, and Clifford Bryant, and Kenny K H Ang, and James H McKerrow, and Brian K Shoichet, and Adam R Renslo
Divergent structure activity relationships in series of enkephalin agonists and cognate antagonists.
January 1983, Life sciences,
Rafaela S Ferreira, and Clifford Bryant, and Kenny K H Ang, and James H McKerrow, and Brian K Shoichet, and Adam R Renslo
Structure-Odor Correlations in Homologous Series of Mercaptoalkanols.
May 2017, Journal of agricultural and food chemistry,
Rafaela S Ferreira, and Clifford Bryant, and Kenny K H Ang, and James H McKerrow, and Brian K Shoichet, and Adam R Renslo
Surface structure evolution in a homologous series of ionic liquids.
February 2018, Proceedings of the National Academy of Sciences of the United States of America,
Rafaela S Ferreira, and Clifford Bryant, and Kenny K H Ang, and James H McKerrow, and Brian K Shoichet, and Adam R Renslo
Pharmacological activities of a homologous series of pyrazole derivatives including quantitative structure-activity relationships (QSAR).
January 1982, Agents and actions. Supplements,
Rafaela S Ferreira, and Clifford Bryant, and Kenny K H Ang, and James H McKerrow, and Brian K Shoichet, and Adam R Renslo
[Structure-activity relationship in a series of homologous cis and trans 2-alkyl-1,3-dioxolanes isomers].
February 1974, Il Farmaco; edizione scientifica,
Rafaela S Ferreira, and Clifford Bryant, and Kenny K H Ang, and James H McKerrow, and Brian K Shoichet, and Adam R Renslo
Structure and stability of a homologous series of tin oxides.
February 2008, Physical review letters,
Rafaela S Ferreira, and Clifford Bryant, and Kenny K H Ang, and James H McKerrow, and Brian K Shoichet, and Adam R Renslo
Studies on the duration of local anaesthesia: structure/activity relationships in a series of homologous local anaesthetics.
November 1977, Acta pharmacologica et toxicologica,
Rafaela S Ferreira, and Clifford Bryant, and Kenny K H Ang, and James H McKerrow, and Brian K Shoichet, and Adam R Renslo
Enzyme inhibition VI: Inhibition of reverse transcriptase activity by protoberberine alkaloids and structure-activity relationships.
May 1983, Journal of pharmaceutical sciences,
Copied contents to your clipboard!